ACYCLOVIR TABLET
Land: Canada
Sprog: engelsk
Kilde: Health Canada
Produktets egenskaber
(SPC)
11-02-2021
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
ACYCLOVIR
Tilgængelig fra:
APOTEX INC
ATC-kode:
J05AB01
INN (International Name):
ACYCLOVIR
Dosering:
200MG
Lægemiddelform:
TABLET
Sammensætning:
ACYCLOVIR 200MG
Indgivelsesvej:
ORAL
Enheder i pakken:
100
Recept type:
Prescription
Terapeutisk område:
NUCLEOSIDES AND NUCLEOTIDES
Produkt oversigt:
Active ingredient group (AIG) number: 0115506002; AHFS:
Autorisation status:
CANCELLED POST MARKET
Autorisation dato:
2012-09-04
Produktets egenskaber
_____________________________________________________________________________________
_ACYCLOVIR Product Monograph _
_ _
_Page 1 of 38_
PRODUCT MONOGRAPH
PR
ACYCLOVIR
ACYCLOVIR TABLETS APOTEX STANDARD
200 MG, 400 MG AND 800 MG
ANTIVIRAL AGENT
APOTEX INC.
DATE OF PREPARATION:
150 SIGNET DRIVE
April 10, 1997
TORONTO, ONTARIO
DATE OF REVISION:
M9L 1T9
February 11, 2021
Control No. 243367
_____________________________________________________________________________________
_ACYCLOVIR Product Monograph _
_Page 2 of 38_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................
3
SUMMARY PRODUCT INFORMATION
..............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
.........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
4
ADVERSE REACTIONS
.........................................................................................................................
6
DRUG
INTERACTIONS..........................................................................................................................
9
DOSAGE AND
ADMINISTRATION......................................................................................................
9
OVERDOSAGE
......................................................................................................................................
11
ACTION AND CLINICAL PHARMACOLOGY
..................................................................................
11
STORAGE AND STABILITY
...............................................................................................................
13
DOSAGE FORMS, COMPOSITION AND PACKAGING
........
Læs hele dokumentet
